Actinomyces israelii is a filamentous, Gram-positive bacterium that is a prominent member of the Actinomyces genus. This bacterium is well-known for its role in causing actinomycosis, a chronic and often indolent infection that can affect various body tissues. Actinomyces israelii is a commensal in the oral cavity and gastrointestinal tract, but it can become pathogenic under certain conditions. Actinomyces israelii infections typically present as cervicofacial actinomycosis, characterized by the formation of abscesses, draining sinuses, and the development of sulfur granules. These sulfur granules, consisting of bacterial colonies and debris, are a hallmark feature of actinomycosis. Diagnosis involves clinical evaluation, imaging studies, and often the identification of sulfur granules in aspirated material. The treatment of Actinomyces israelii infections generally requires prolonged antibiotic therapy, with penicillin being the drug of choice. Surgical drainage or excision may be necessary for extensive abscesses. While actinomycosis caused by Actinomyces israelii can be challenging to diagnose and manage, prompt and appropriate intervention can lead to favorable outcomes.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France